Key Highlights

Risk & Performance

Pipeline Risk Assessment

Based on historical performance

High Risk

Score: 60/100

Failure Rate

10.0%

1 terminated/withdrawn out of 10 trials

Success Rate

50.0%

-36.5% vs industry average

Late-Stage Pipeline

30%

3 trials in Phase 3/4

Results Transparency

0 of 1 completed trials have results

Key Signals

5 recruiting

Enrollment Performance

Analytics

N/A

5(55.6%)

Phase 3

3(33.3%)

Phase 2

1(11.1%)

9Total

N/A(5)

Phase 3(3)

Phase 2(1)

Activity Timeline

Global Presence

Loading network data...

Clinical Trials (10)

Showing 10 of 10 trials

NCT03540420Phase 2Active Not Recruiting

Atezolizumab After Concurrent Chemo-radiotherapy Versus Chemo-radiotherapy Alone in Limited Disease Small-cell Lung Cancer

Role: collaborator

NCT06419946Phase 3Recruiting

Lomustine in Addition to Standard of Care in Patients With MGMT Methylated Glioblastoma

Role: collaborator

NCT06488482Phase 3Recruiting

Assessment of Short Immunotherapy After Radical Surgery of High-risk Malignant Melanoma

Role: collaborator

NCT05223647Phase 3Terminated

Chemo-immunotherapy Plus Thoracic Radiotherapy in Extensive Stage Small-cell Lung Cancer

Role: collaborator

NCT06446401Recruiting

The Case of "Triple" Versus "Double" Therapy for Patients With High Volume Metastatic Hormone Sensitive Prostate Cancer

Role: collaborator

NCT03259204Not ApplicableRecruiting

Swedish Multicenter Trial of Outpatient Prevention of Leg Clots

Role: collaborator

NCT02767505Not ApplicableActive Not Recruiting

Bypass Equipoise Sleeve Trial (BEST)

Role: collaborator

NCT05621902Not ApplicableNot Yet Recruiting

Web-based Symptom Monitoring and Survival in Advanced Stage Lung Cancer

Role: collaborator

NCT05377047Not ApplicableRecruiting

Stereotactic Ablative Radiotherapy for OligoMetastatic Breast Cancer

Role: collaborator

NCT00494793Not ApplicableCompleted

Vacuum Assisted Wound Closure (VAWC) and Mesh Mediated Fascial Traction

Role: collaborator

All 10 trials loaded